Onvuzosiran (sodium)
Onvuzosiran sodium, a siRNA, is a prekallikrein synthesis reducer.
Product Specifications
UNSPSC
12352208
Target
Kallikrein
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Onvuzosiran(sodium)]
Molecular Formula
C534H661F15N180Na46O329P44S8
Molecular Weight
17826.80
References & Citations
[1]WHO Drug Information - Vol. 38 , No. 4, 2024
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-177652A/
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6389603-01 0.1 mL
PKN3 (Serine/Threonine-protein Kinase N3, Protein Kinase PKN-beta, Protein-kinase C-related Kinase 3, PKNBETA, RP11-545E17.1) (AP)
Ask
View Details MBS6389603-02 5x 0.1 mL
PKN3 (Serine/Threonine-protein Kinase N3, Protein Kinase PKN-beta, Protein-kinase C-related Kinase 3, PKNBETA, RP11-545E17.1) (AP)
Ask
View Details 
